Tudor Investment Corp’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-72,579
| Closed | -$377K | – | 2229 |
|
|
2024
Q3 | $377K | Buy |
72,579
+29,360
| +68% | +$152K | ﹤0.01% | 1288 |
|
|
2024
Q2 | $111K | Buy |
43,219
+10,878
| +34% | +$28K | ﹤0.01% | 1399 |
|
|
2024
Q1 | $159K | Buy |
+32,341
| New | +$159K | ﹤0.01% | 1344 |
|
|
2023
Q2 | – | Sell |
-19,719
| Closed | -$635K | – | 2062 |
|
|
2023
Q1 | $635K | Sell |
19,719
-21,357
| -52% | -$688K | 0.01% | 1063 |
|
|
2022
Q4 | $758K | Buy |
+41,076
| New | +$758K | 0.02% | 975 |
|
|
2022
Q3 | – | Sell |
-74,119
| Closed | -$1.02M | – | 2068 |
|
|
2022
Q2 | $1.02M | Sell |
74,119
-15,453
| -17% | -$213K | 0.03% | 796 |
|
|
2022
Q1 | $1.75M | Buy |
+89,572
| New | +$1.75M | 0.04% | 599 |
|
|
2021
Q3 | – | Sell |
-64,616
| Closed | -$1.92M | – | 2062 |
|
|
2021
Q2 | $1.92M | Buy |
+64,616
| New | +$1.92M | 0.04% | 550 |
|
|
2016
Q3 | – | Sell |
-27,200
| Closed | -$370K | – | 1647 |
|
|
2016
Q2 | $370K | Buy |
+27,200
| New | +$370K | 0.01% | 883 |
|
|
2016
Q1 | – | Sell |
-11,000
| Closed | -$376K | – | 1753 |
|
|
2015
Q4 | $376K | Buy |
+11,000
| New | +$376K | 0.01% | 956 |
|